Constellation Pharmaceuticals Inc (CNST) Forecast, Price Target & Analyst Ratings

NASDAQ:CNST

Current stock price

33.99
+0.02 (+0.06%)
At close:
33.99
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Constellation Pharmaceuticals Inc (CNST).

Forecast Snapshot

Consensus Price Target

Price Target
$41.53
+ 22.18% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 4, 2022
Period
Q2 / 2021
EPS Estimate
-$0.90
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
71.40%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$41.53
Upside
+ 22.18%
From current price of $33.99 to mean target of $41.53, Based on 7 analyst forecasts
Low
$34.34
Median
$34.68
High
$78.75

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for CNST. The average price target is 41.53 null. This implies a price increase of 22.18% is expected in the next year compared to the current price of 33.99.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CNST Current Analyst RatingCNST Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

CNST Historical Analyst RatingsCNST Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
71.40%
CNST was analyzed by 7 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about CNST.
In the previous month the buy percentage consensus was at a similar level.
CNST was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 4, 2022
Period
Q2 / 2021
EPS Estimate
-$0.90
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-28.55%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

CNST is expected to report earnings on 3/4/2022. The consensus EPS estimate for the next earnings is -0.9 null and the consensus revenue estimate is 0 null.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2021 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
CNST revenue by date.CNST revenue by date.
N/AN/AN/AN/AN/AN/A
1,157.23%		N/A
146.31%		N/A
150.00%
EBITDA
YoY % growth
CNST ebitda by date.CNST ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CNST ebit by date.CNST ebit by date.
N/AN/AN/AN/AN/AN/AN/AN/A
Operating Margin
CNST operating margin by date.CNST operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CNST eps by date.CNST eps by date.
N/A-3.06
29.08%		-2.81
8.17%		N/A
-28.75%		N/A
-8.42%		N/A
1.49%		N/A
5.36%		N/A

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 21 Q3 / 21 Q4 / 21 Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth		-0.90
-28.55%		-0.93
-30.89%		-0.94
-19.09%		-1.04
-23.86%		-1.08
-20.15%		-1.12
-20.73%		-1.04
-10.58%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/A

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CNST Yearly Revenue VS EstimatesCNST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 50M 100M 150M
CNST Yearly EPS VS EstimatesCNST Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -1 -2 -3 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-11.20%
EPS Next 5 Year
-5.41%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Constellation Pharmaceuticals Inc / CNST Forecast FAQ

Can you provide the average price target for Constellation Pharmaceuticals Inc stock?

7 analysts have analysed CNST and the average price target is 41.53 null. This implies a price increase of 22.18% is expected in the next year compared to the current price of 33.99.

Can you provide the upcoming earnings date for Constellation Pharmaceuticals Inc?

Constellation Pharmaceuticals Inc (CNST) will report earnings on 2022-03-04, before the market open.

What are the consensus estimates for Constellation Pharmaceuticals Inc (CNST) next earnings?

The consensus EPS estimate for the next earnings of Constellation Pharmaceuticals Inc (CNST) is -0.9 null and the consensus revenue estimate is 0 null.

What is the consensus rating for Constellation Pharmaceuticals Inc (CNST) stock?

The consensus rating for Constellation Pharmaceuticals Inc (CNST) is 71.4 / 100 . This indicates that analysts generally have a positive outlook on the stock.